Executive Director​/VP, Clinical Pharmacology D300-1065

Executive Director / VP, Clinical Pharmacology
US, Remote

Required Experience:

Clinical Pharmacology, 10+ years

Clinical Pharmacology, 10+ years

• Team managment, +5 years
• Pharma Bio industry, 15+ years

PhD or Pharm D, preferred

PhD or Pharm D, preferred

Executive Director / Vice President – Clinical Pharmacology

Confidential Clinical-Stage Biopharma (Oncology Focus)

Company Overview

• Therapeutic Area:
  Oncology, with emphasis on RAS- and Kinase-driven malignancies
• Stage:
  Clinical-stage, expanding rapidly across research, clinical, and translational functions
• Culture:
  Agile, science-driven, collaborative, with a mission-oriented focus on improving patient outcomes

Position Highlights

Title:

Executive Director / Vice President, Clinical Pharmacology, Remote US

Location:

Remote (U.S. based, with strong preference for major biotech hubs)

Compensation: $290,000 - $330,000 base + bonus, equity, and full benefits

• Lead the clinical pharmacology strategy across multiple oncology programs, ensuring scientific rigor and regulatory alignment.
• Oversee the design and execution of clinical pharmacology studies, including first-in-human and proof-of-concept trials.
• Apply model-informed drug development (MIDD) approaches, including PBPK, PK/PD, population PK, and exposure-response analyses.
• Serve as regulatory lead for clinical pharmacology, authoring IND, CTA, NDA modules and engaging with FDA/global health authorities.
• Collaborate with cross-functional leaders in clinical operations, regulatory, biostatistics, and translational medicine to advance pipeline assets.
• Stay on the forefront of innovation in clinical pharmacology and oncology, contributing thought leadership to the field.

• Ph.D. or equivalent in Clinical Pharmacology, Pharmacokinetics/Pharmacodynamics, or related field
• 10-15+ years of experience in oncology clinical pharmacology, ideally with small molecules in solid tumors
• Strong track record of regulatory submissions and successful advancement of oncology programs into late-stage development
• Expertise in quantitative pharmacology (PBPK, exposure-response, population PK/PD)
• Excellent cross-functional leadership skills and ability to operate in a fast-paced biotech environment

• Impact:
  Lead clinical pharmacology strategy in a company poised to change treatment paradigms in oncology
• Visibility:
  Direct interaction with executive leadership and global regulators
• Growth:
  Opportunity to shape multiple oncology programs and influence portfolio strategy
• Rewards:
  Competitive total compensation with equity participation in a high-growth biopharma

GRN Boston North

633 Waverly Road

Suite 100

North Andover, MA 01845 USA